Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GUARNOTTA, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.315
EU - Europa 4.897
AS - Asia 4.573
SA - Sud America 871
Continente sconosciuto - Info sul continente non disponibili 844
AF - Africa 138
OC - Oceania 11
Totale 21.649
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.086
SG - Singapore 1.624
IT - Italia 1.345
RU - Federazione Russa 1.224
CN - Cina 1.124
BR - Brasile 648
HK - Hong Kong 503
DE - Germania 463
VN - Vietnam 449
FI - Finlandia 411
PL - Polonia 319
FR - Francia 281
GB - Regno Unito 224
BD - Bangladesh 196
IE - Irlanda 158
UA - Ucraina 146
JP - Giappone 139
CA - Canada 95
KR - Corea 94
IN - India 87
SE - Svezia 76
TR - Turchia 72
AR - Argentina 69
MX - Messico 60
NL - Olanda 55
IQ - Iraq 53
CO - Colombia 41
AT - Austria 40
ZA - Sudafrica 35
BE - Belgio 33
EC - Ecuador 33
MA - Marocco 28
ES - Italia 27
UZ - Uzbekistan 24
RO - Romania 23
VE - Venezuela 22
PK - Pakistan 20
CL - Cile 19
KE - Kenya 19
NP - Nepal 19
SA - Arabia Saudita 18
CI - Costa d'Avorio 16
JM - Giamaica 16
CR - Costa Rica 15
ID - Indonesia 15
MY - Malesia 15
PH - Filippine 15
TN - Tunisia 15
AE - Emirati Arabi Uniti 14
PE - Perù 14
GR - Grecia 13
IR - Iran 12
PY - Paraguay 12
AU - Australia 10
LT - Lituania 10
TW - Taiwan 10
CH - Svizzera 9
JO - Giordania 9
BO - Bolivia 8
EG - Egitto 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
DK - Danimarca 7
GT - Guatemala 7
HN - Honduras 7
KZ - Kazakistan 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
SY - Repubblica araba siriana 6
AL - Albania 5
HR - Croazia 5
IL - Israele 5
NI - Nicaragua 5
TH - Thailandia 5
UY - Uruguay 5
KG - Kirghizistan 4
PA - Panama 4
BG - Bulgaria 3
CY - Cipro 3
KH - Cambogia 3
LB - Libano 3
MK - Macedonia 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
TG - Togo 2
AF - Afghanistan, Repubblica islamica di 1
Totale 20.788
Salva come PNG Salva come JPEG
Città #
Ashburn 1.145
Singapore 1.006
San Jose 941
Fairfield 886
Houston 501
Hong Kong 481
Woodbridge 448
Chandler 393
Seattle 386
Council Bluffs 385
Wilmington 382
Cambridge 278
Zgierz 270
Ann Arbor 249
Palermo 212
Moscow 206
Bryn Mawr 199
Beijing 192
Medford 160
Dublin 155
Los Angeles 150
Helsinki 149
New York 148
Ho Chi Minh City 144
Dallas 135
Tokyo 134
Lauterbourg 131
Santa Clara 127
Munich 117
Hanoi 115
Chicago 100
Des Moines 99
Princeton 99
Altamura 97
Nanjing 91
Boardman 83
Jacksonville 72
Hefei 71
Frankfurt am Main 67
Lawrence 64
Milan 64
San Diego 58
Rome 55
Buffalo 54
São Paulo 54
Phoenix 50
London 48
Ludwigshafen am Rhein 48
Atlanta 45
The Dalles 45
Dearborn 43
Izmir 39
Orem 38
Jinan 36
Nanchang 35
Changsha 34
Toronto 34
Shenyang 32
Brussels 31
Denver 31
Lappeenranta 31
Tianjin 31
Columbus 30
Nuremberg 30
Rio de Janeiro 29
Warsaw 29
Hebei 28
Tulsa 27
Springfield 26
Ningbo 25
Baghdad 24
Da Nang 24
Guangzhou 24
Jiaxing 24
San Francisco 24
Redwood City 23
Montreal 22
Naples 22
Amsterdam 20
Brooklyn 19
Falls Church 18
Zhengzhou 18
Boston 17
Chennai 17
Hangzhou 17
Johannesburg 17
Quito 17
Seoul 17
Tashkent 17
Abidjan 16
Nairobi 16
Salt Lake City 16
Shanghai 16
Vienna 16
Brasília 15
Haiphong 15
Bucheon-si 14
Paris 14
Saint Petersburg 14
Turin 14
Totale 12.775
Salva come PNG Salva come JPEG
Nome #
The Daily Consumption of Cola Can Determine Hypocalcemia: A Case Report of Postsurgical Hypoparathyroidism-Related Hypocalcemia Refractory to Supplemental Therapy with High Doses of Oral Calcium 614
Body composition assessment for the definition of cardiometabolic risk. 438
COLORECTAL CANCER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A SINGLE-CENTRE EXPERIENCE. 398
Valutazione dell’insulino-sensibilità tramite clamp euglicemico iperinsulinemico in bambini in terapia sostitutiva con GH. 380
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory 342
Superior mesenteric artery syndrome: Clinical, endoscopic, and radiological findings 308
Development of a fuzzy expert system for the control of glycemia in type 1 diabetic patients 262
Hepatic steatosis index in acromegaly: Correlation with insulin resistance regardless of the disease control 262
NANOG plays a hierarchical role in the transcription network regulating the pluripotency and plasticity of adipose tissue-derived stem cells 259
Anti-Inflammatory Action of Heterogeneous Nuclear Ribonucleoprotein A2/B1 in Patients with Autoimmune Endocrine Disorders 251
Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia 250
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 247
Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency 240
Circulating Irisin Levels in Children with GH Deficiency before and after 1 Year of GH Treatment 236
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome 235
Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency 227
Extracellular vesicles as a novel immunotherapeutic strategy in hashimoto’s thyroiditis: advances in targeted delivery technologies 225
Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency 218
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment. 214
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy (APECED) in Sicily: confirmation that R203X is the peculiar AIRE gene mutation. 212
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. 210
Relationship between body fat distribution and blood disorders in patients with visceral obesity with and without diabetes mellitus 208
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. 207
The metabolic outcomes of growth hormone treatment in children are gender specific 205
The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency 202
Growth hormone and hematopoiesis: A retrospective analysis on a large cohort of children with growth hormone deficiency 199
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 198
Insulin sensitivity and secretion and adipokine profile in patients with Cushing’s disease treated with pasireotide 197
Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis 196
Is diabetes in Cushing's syndrome only a consequence of hypercortisolism? 195
Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children 194
Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease 193
Pasireotide versus pituitary surgery: a retrospective analysis of 12 months of treatment in patients with Cushing's disease 192
COVID-19 and the Pancreas: A Narrative Review 190
Correlation between Severity of Growth Hormone Deficiency and Thyroid Metabolism and Effects of Long-Term Growth Hormone Treatment on Thyroid Function in Children with Idiopathic Growth Hormone Deficiency. 190
NEW THERAPEUTIC PERSPECTIVES IN IRRITABLE BOWEL SYNDROME: TARGETING LOW-GRADE INFLAMMATION, IMMUNO-NEUROENDOCRINE AXIS, MOTILITY, SDECRETION AND BEYOND 189
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence” 186
Alte dosi di cabergolina migliorano i parametri metabolici in pazienti affetti da prolattinoma. 185
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. 183
Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: A retrospective analysis 181
Impact of atorvastatin plus n-3 PUFA on metabolic, inflammatory and coagulative parameters in metabolic syndrome without and with type 2 diabetes mellitus 179
Efficacy and safety of everolimus in extrapancreatic neuroendocrine tumor: A comprehensive review of literature 179
Alta prevalenza di Sindrome dell’ovaio policistico in donne diabetiche di tipo 1 in età fertile. 178
Circulating adipokine levels in diabetic patients with Cushing disease on pasireotide treatment compared with patients with type 2 diabetes mellitus 178
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY VS. DUAL-RELEASE HYDROCORTISONE: EFFECTS ON INFLAMMATION AND IMMUNE PROFILE IN PATIENTS WITH PRIMARY ADRENAL INSUFFICIENCY AND IMPLICATIONS OF THERAPY RESPONSE PREDICTORS 177
Sviluppo di un sistema di supporto decisionale tipo Fuzzy per il controllo della glicemia post-prandiale nel diabete mellito tipo 1 177
Efficacia della associazione Atorvastatina e n-3 PUFA in pazienti affetti da dislipidemia combinata e ad alto rischio di eventi cardiovascolari 174
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions 174
Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report 168
Effetti a lungo termine del trattamento con Simvastatina ed Ezetimibe sui livelli di HDL-C e hs-PCR in pazienti affetti da Ipercolesterolemia familare(FH) con pregresso IMA e/o Lesione carotidea 167
Comparison of clinical and metabolic effects of pasireotide and pituitary surgery in Cushing disease 164
Clinical and metabolic impact of three-times-weekly versus daily growth hormone (GH) treatment in naïve GH-deficient children 163
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia 163
Maggiore rischio cardiometabolico in pazienti di razza non caucasica affetti da diabete mellito di tipo 1 idiopatico rispetto alla forma autoimmune in pazienti caucasici. 162
Utilizzo del Visceral Adiposity Index per l’identificazione di donne con sindrome iperandrogenica a rischio cardiometabolico. 160
Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study 160
The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma? 159
EFFECTS OF PASIREOTIDE TREATMENT ON CARDIOMETABOLIC RISK IN PATIENTS WITH CUSHING’S DISEASE : AN ITALIAN, MULTICENTER STUDY 157
Effects of osilodrostat and metyrapone on 2D and 3D models of adrenocortical carcinoma cell lines viability: preliminary results 156
Off-line control of the postprandial glycemia in type 1 diabetes patients by a fuzzy logic decision support 155
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group 154
The adipose visceral dysfunction plays an important role in diabetes in Cushing disease. 153
Insulin sensitivity and visceral adiposity index (VAI) in women with functional secondary amenorrhea. 152
IL CONSUMO DI BEVANDE RICCHE DI ACIDO ORTOFOSFORICO COME FATTORE DI RISCHIO PER LO SVILUPPO DI IPOCALCEMIA: IL CASO DI UNA DONNA CON IPOPARATIROIDISMO POST-CHIRURGICO 150
Miglioramento clinico e metabolico in pazienti affetti da diabete mellito tipo 1 associato ad altre endocrinopatie (APS) dopo shift della terapia insulinica basale con glargine a degludec 149
Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine System 142
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia, severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations in acromegaly due to a therapeutically resistant pituitary GH-secreting macroadenoma 141
GH-treatment improves growth and reduces the severity of fibrosis and hypertansaminasemia in a prepubertal child with sclerosant cholangiopathy 139
Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease 138
IPOVITAMINOSI D ED EFFETTI BENEFICI DELLA TERAPIA SOSTITUTIVA CON GH SUI LIVELLI DI VITAMINA D IN BAMBINI AFFETTI DA DEFICIT DI GH 137
Improved cardiovascular and cardiometabolic risk in patients with type 1 diabetes and autoimmune polyglandular syndrome switched from glargine to degludec due to hypoglycaemic variability 135
Evidence of greater severity of diabetic foot ulcers during COVID-19 pandemic: A real-life single-centre cohort study 134
Very Low-Calorie Ketogenic Diet: A Potential Application in the Treatment of Hypercortisolism Comorbidities 133
Miglioramento dell'insulino-sensibilità e dell'insulino-secrezione dopo switch da terapia con glucocorticoidi tradizionali a idrocortisone "dual release" in pazienti affetti da iposurrenalismo 132
Ultrasound Parameters Can Accurately Predict the Risk of Malignancy in Patients with "Indeterminate TIR3b" Cytology Nodules: A Prospective Study 129
Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: A real-life study 129
Modificazioni di insulino-secrezione, insulino-sensibilità e funzione adiposa durante terapia con pasireotide in un gruppo di pazienti con malattia di Cushing 128
Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily. 125
Effects of the ketogenic diet compared to the mediterranean diet in patients with acromegaly 125
Influence of the Microbiota Through the Gut-Brain Axis in Neurological Diseases 124
Who and how to screen for endogenous hypercortisolism in type 2 diabetes mellitus or obesity 123
Poor diagnostic value of the euglycemic-hyperinsulinemic clamp in the clinical assessment of insulin resistant women with PCOS. 123
Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers. 123
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins 122
Traitement séquential avec des corticostéroides dans les ophtalmopathy Graves 122
Correction to: One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus 122
ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus. 122
LONG-TERM METABOLIC EFFECTS OF GH THERAPY IN CHILDREN WITH IDIOPATHIC GH DEFICIENCY 121
EFFECT OF SWITCH FROM CONVENTIONAL GLUCOCORTICOIDS TO “DUAL RELEASE HYDROCORTISONE” (DR-HC) ON METABOLIC PROFILE AND QUALITY OF LIFE IN ADULT PATIENTS WITH SECONDARY ADRENAL INSUFFICIENCY (SAI): RESULTS OF THREE MONTHS FOLLOW-UP 121
Predictive factors of polycystic ovary syndrome in girls with precocious pubarche 121
Maggior rischio cardiometabolico nelle donne affette da Cushing, anche in assenza di una franca Sindrome Metabolica. 120
More favorable metabolic impact of three-times-weekly versus daily growth hormone (GH) treatment in naïve GH-deficient children 118
GENOMIC AND PROTEOMIC EVALUATION OF VISCERAL AND SUBCUTANEOUS ADIPOSE DERIVED STEM CELLS AND FUNCTIONAL ROLES OF PLURIPOTENCY TRANSCRIPTION FACTORS 117
Ketogenic Diet in Steatotic Liver Disease: A Metabolic Approach to Hepatic Health 116
Adrenal Cushing’s syndrome in children 114
INSULIN SECRETION AND SENSITIVITY DURING PASIREOTIDE TREATMENT IN PATIENTS WITH RECURRENT CUSHING DISEASE: A CASE SERIES 114
Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study 114
Glucocorticoid excess and COVID-19 disease 114
Dual-release hydrocortisone treatment improves serum and peripheral blood mononuclear cell inflammatory and immune profiles in patients with autoimmune primary adrenal insufficiency 112
Valutazione dell’insulino-sensibilità e della funzione adiposa viscerale nel diabete mellito tipo 1 autoimmune ed idiopatico. 112
Totale 18.188
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022918 0 0 0 62 45 59 46 65 199 161 55 226
2022/20231.357 146 261 22 122 139 190 75 110 188 8 62 34
2023/2024710 26 98 27 64 53 167 102 49 10 26 17 71
2024/20252.393 68 126 132 201 52 99 159 243 185 244 269 615
2025/20268.294 511 266 521 704 671 1.110 1.296 866 674 774 452 449
2026/20272.128 841 327 899 61 0 0 0 0 0 0 0 0
Totale 21.649